Axsome Therapeutics Inc (AXSM)
74.12
+1.36
(+1.87%)
USD |
NASDAQ |
Jun 02, 16:00
75.75
+1.63
(+2.20%)
After-Hours: 20:00
Axsome Therapeutics Revenue (TTM): 144.61M for March 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | 144.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
144.61M
Minimum
Mar 2023
144.61M
Maximum
Mar 2023
144.61M
Average
144.61M
Median
Mar 2023
Revenue (TTM) Benchmarks
| Vertex Pharmaceuticals Inc | 9.208B |
| Eli Lilly and Co | 27.69B |
| Pfizer Inc | 92.95B |
| Sarepta Therapeutics Inc | 975.68M |
| Reata Pharmaceuticals Inc | -- |